Company Profile:
At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve launched this novel/novel combination therapy in the U.S. and are exploring pathways for Europe and Japan. We continue to advance our pipeline of drugs to help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. This is an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients.
Position Overview
We seek a Development Strategy and Operations Lead to advance our VS-7375 program by connecting clinical insights with strategy and execution. This role leads critical projects, aligns cross-functional teams, and supports key development decisions.
Key Responsibilities
Qualifications
Preferred
Copyright © 2026 Grabjobs Pte.Ltd. All Rights Reserved.